ARTV
Artiva Biotherapeutics
$6.16
+$0.01 (+0.16%)Oct 26, 2026
Key metrics
The numbers that frame ARTV today
- Market cap
- $301.16M
- ROIC
- -97.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.96
- 52wk High
- $14.53
Growth
Revenue and earnings trend for ARTV
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ARTV
Is Artiva Biotherapeutics a good buy?
No. Artiva Biotherapeutics has strong momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think Artiva Biotherapeutics is selling at a very high price.
What is the market capitalization of ARTV?
Artiva Biotherapeutics's market capitalization is $301.16M.
What is the 52-week high for ARTV stock?
The 52-week high for Artiva Biotherapeutics is $14.53. The current close of $6.16 is 57.6% below that high.
What is the 52-week low for ARTV stock?
The 52-week low for Artiva Biotherapeutics is $2.96. The current close of $6.16 is 108.1% above that low.
Does ARTV stock pay dividends?
Artiva Biotherapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ARTV?
Artiva Biotherapeutics's Debt / Equity ratio is 0.03.